Skip to content
Search

Latest Stories

EXCLUSIVE: Ten years forward ten years backwards

By Bhavisha Patel

Ten years ago, I dreamt of becoming a pharmacist. In fact, I was dead set on it. Whilst embarking my A-Levels all I wished for was to get the grades to get me on an MPharm course. I did undertake some work experience in a community pharmacy setting, which I used in my personal statement for my UCAS application. Ten years later, I’ve fulfilled the dream of becoming a pharmacist.


Currently, I am a community pharmacist who predominantly works for a pharmacy chain. Community pharmacy itself has changed quite drastically in the last few years and with the introduction of Community Pharmacist Consultation Service it looks as if community pharmacy is about to get a lot more clinical. Despite being newly qualified, I still felt there was room for improvement in terms of further advancing my clinical skills. The Pharmacy Integration Fund had funding to undergo a postgraduate certificate in Clinical Pharmacy, and I thought this was a perfect way to develop myself.

I applied and enrolled myself onto the Clinical Community Pharmacy Postgraduate Programme at Bath University. The course itself is predominantly distance learning, with a faceto-face day for each module that’s undertaken. For me personally, having done some distance learning prior to starting this course, I knew this type of learning suited me as it would allow me to study and work at the same time.

Furthermore, I found face-to-face days incredibly useful in keeping me engaged and motivated throughout each module, in order to complete the course.

On our first face-to-face day, we learnt how to take manual blood pressure reading. This wasn’t something that was completely new to me, but I never got to use it in practice. Having that refresher on how to undertake a manual blood pressure reading, highlighted I am still as hopeless a as I was during university.

Having seen my peers manage to do this successfully has motivated me to get this skill mastered by the end of the year. Moreover, when implementing this skill in front of patients it’s going to get them talking. After all you do associate a stethoscope with a doctor; but if we can become competent in providing that service, why not?

We all identify gaps in our knowledge; and our annual CPD’s are reflective of this. But there are opportunities available for everyone to develop themselves as pharmacists; whether it be clinical, managerial or even research – we just have to find it. The skills that I learn undertaking this postgraduate course I can apply in my current role as a pharmacist, in another setting as a pharmacist, or even in an alternative role. In ten-years’ time I may still be a community pharmacist.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less